Defender Capital’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,587
| Closed | -$370K | – | 38 |
|
|
2022
Q1 | $370K | Hold |
8,587
| – | – | 0.13% | 27 |
|
|
2021
Q4 | $514K | Sell |
8,587
-1,869
| -18% | -$112K | 0.16% | 28 |
|
|
2021
Q3 | $887K | Sell |
10,456
-833
| -7% | -$70.7K | 0.29% | 21 |
|
|
2021
Q2 | $1.26M | Buy |
11,289
+417
| +4% | +$46.4K | 0.42% | 18 |
|
|
2021
Q1 | $1.21M | Buy |
10,872
+2,581
| +31% | +$287K | 0.43% | 20 |
|
|
2020
Q4 | $881K | Sell |
8,291
-1,702
| -17% | -$181K | 0.38% | 19 |
|
|
2020
Q3 | $1.39M | Buy |
9,993
+6,639
| +198% | +$924K | 0.69% | 14 |
|
|
2020
Q2 | $1.08M | Sell |
3,354
-15,668
| -82% | -$5.06M | 0.64% | 14 |
|
|
2020
Q1 | $1.7M | Sell |
19,022
-28,545
| -60% | -$2.55M | 1.24% | 13 |
|
|
2019
Q4 | $1.88M | Sell |
47,567
-4,291
| -8% | -$170K | 1.67% | 12 |
|
|
2019
Q3 | $1.28M | Sell |
51,858
-2,209
| -4% | -$54.5K | 1.13% | 11 |
|
|
2019
Q2 | $1.92M | Sell |
54,067
-3,633
| -6% | -$129K | 1.55% | 10 |
|
|
2019
Q1 | $2.55M | Buy |
57,700
+9,275
| +19% | +$410K | 2.04% | 10 |
|
|
2018
Q4 | $2.32M | Buy |
+48,425
| New | +$2.32M | 2.21% | 10 |
|